ANADYS PHARMACEUTICALS INC 4
4 · ANADYS PHARMACEUTICALS INC · Filed Aug 6, 2008
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2008-08-05+50,000→ 50,000 totalExercise: $2.74From: 2009-08-05Exp: 2018-08-04→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Granted in connection with Dr. Freddo's expansion of responsibility from Chief Medical Officer to Sr. Vice President, Drug Development and Chief Medical Officer.
- [F2]25% of the shares subject to the option shall vest and become exercisable one year from the date of the grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next three year period such that all shares subject to the option will be fully vested and exercisable as of August 5, 2012.